Vijaya Diagnostic Centre Limited (NSE:VIJAYA)

Market Cap	101.67B +5.2%
Revenue (ttm)	7.68B +16.6%
Net Income	1.59B +12.2%
EPS	15.48 +12.1%
Shares Out	102.90M
PE Ratio	63.82
Forward PE	49.73
Dividend	2.00 (0.20%)
Ex-Dividend Date	Aug 29, 2025

Volume	67,500
Average Volume	93,974
Open	987.90
Previous Close	988.05
Day's Range	986.60 - 1,019.95
52-Week Range	740.00 - 1,180.00
Beta	-0.19
RSI	49.38
Earnings Date	Feb 3, 2026

About Vijaya Diagnostic Centre

Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyder...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 2,218
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIJAYA

Financial Performance

In fiscal year 2025, Vijaya Diagnostic Centre's revenue was 6.81 billion, an increase of 24.39% compared to the previous year's 5.48 billion. Earnings were 1.43 billion, an increase of 20.41%.